Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: An 8-week, double-blind, randomized add-on two-center trial

The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia

(2011) M.S. Ritsner   NEUROSCIENCE

Pregnenolone, Dehydroepiandrosterone, and Schizophrenia: Alterations and Clinical Trials

(2010) Michael S. Ritsner   CNS Neuroscience & Therapeutics

Pregnenolone and Dehydroepiandrosterone as an Adjunctive Treatment in Schizophrenia and Schizoaffective Disorder

(2010) Michael S. Ritsner et al.   JOURNAL OF CLINICAL PSYCHIATRY

Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

(2009) Christine E Marx et al.   NEUROPSYCHOPHARMACOLOGY

Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice

(2008) Christine E. Marx et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: Mechanism of action and relevance to psychiatric disorders

(2007) Iván Pérez-Neri et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY